Human serum albumin improves arterial dysfunction during early resuscitation in mouse endotoxic model via reduced oxidative and nitrosative stresses

American Journal of Pathology

Volumn 171, Issue 6, 2007, Pages 1753-1761

  Meziani, Ferhat ^a,b,c,d,e   Kremer, Hélène ^b,c,f   Tesse, Angela ^a   Baron Menguy, Céline ^a   Mathien, Cyrille ^b,c,f   Mostefai, H Ahmed ^a   Carusio, Nunzia ^a   Schneider, Francis ^f   Asfar, Pierre ^d,e   Andriantsitohaina, Ramaroson ^a  

^a INSERM   (France)

^b CNRS   (France)

^c UNIVERSITÉ D'ANGERS   (France)

^d UNIVERSITÉ DE STRASBOURG   (France)

^e ANGERS UNIVERSITY HOSPITAL   (France)

^f UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; HUMAN SERUM ALBUMIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; OXYGEN; PEROXYNITRITE; PHENYLEPHRINE; SODIUM CHLORIDE; SUPEROXIDE; UNCLASSIFIED DRUG; VIALEBEX;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; AORTA; ARTERY DIAMETER; ARTERY DISEASE; ARTERY ENDOTHELIUM; ARTERY TONE; ARTERY WALL; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIAL DYSFUNCTION; ENDOTOXEMIA; EXPERIMENTAL MODEL; HEART RATE; IMMUNOHISTOCHEMISTRY; MALE; MEAN ARTERIAL PRESSURE; MESENTERIC ARTERY; MOUSE; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RESUSCITATION; SPIN TRAPPING; TREATMENT OUTCOME; UPREGULATION; WESTERN BLOTTING;

EID: 38349064946     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2007.070316     Document Type: Article

References (30)

1. Parrillo JE: Pathogenetic mechanisms of septic shock. N Engl J Med 1993, 328:1471-1477
2. Russell JA: Management of sepsis. N Engl J Med 2006, 355:1699-1713
3. Court O, Kumar A, Parrillo JE, Kumar A: Clinical review: myocardial depression in sepsis and septic shock. Crit Care 2002, 6:500-508
4. Rivers EP, McIntyre L, Morro DC, Rivers KK: Early and innovative interventions for severe sepsis and septic shock: taking advantage of a window of opportunity. CMAJ 2005, 173:1054-1065
5. Victor VM, Rocha M, De la Fuente M: Immune cells: free radicals and antioxidants in sepsis. Int Immunopharmacol 2004, 4:327-347
6. Clapp BR, Hingorani AD, Kharbanda RK, Mohamed-Ali V, Stephens JW, Vallance P, MacAllister RJ: Inflammation-induced endothelial dysfunction involves reduced nitric oxide bioavailability and increased oxidant stress. Cardiovasc Res 2004, 64:172-178
7. Peters K, Unger RE, Brunner J, Kirkpatrick CJ: Molecular basis of endothelial dysfunction in sepsis. Cardiovasc Res 2003, 60:49-57
8. Orfanos SE, Mavrommati I, Korovesi I, Roussos C: Pulmonary endothelium in acute lung injury: from basic science to the critically ill. Intensive Care Med 2004, 30:1702-1714
9. Stoclet JC, Muller B, Andriantsitohaina R, Kleschyov A: Overproduction of nitric oxide in pathophysiology of blood vessels. Biochemistry (Mosc) 1998, 63:826-832
10. Stoclet JC, Martinez MC, Ohlmann P, Chasserot S, Schott C, Kleschyov AL, Schneider F, Andriantsitohaina R: Induction of nitric oxide synthase and dual effects of nitric oxide and cyclooxygenase products in regulation of arterial contraction in human septic shock. Circulation 1999, 100:107-112
11. Quinlan GJ, Martin GS, Evans TW: Albumin: biochemical properties and therapeutic potential. Hepatology 2005, 41:1211-1219
12. Sakurai Y, Ma SF, Watanabe H, Yamaotsu N, Hirono S, Kurono Y, Kragh-Hansen U, Otagiri M: Esterase-like activity of serum albumin: characterization of its structural chemistry using p-nitrophenyl esters as substrates. Pharm Res 2004, 21:285-292
13. Cantin AM, Paquette B, Richter M, Larivee P: Albumin-mediated regulation of cellular glutathione and nuclear factor kappa B activation. Am J Respir Crit Care Med 2000, 162:1539-1546
14. Margarson MP, Soni NC: Effects of albumin supplementation on microvascular permeability in septic patients. J Appl Physiol 2002, 92:2139-2145
15. Finfer SBR, Boyce N, French J, Myburgh J, Norton R: SAFE Study Investigators: a comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004, 350:2247-2256
16. Dubois MJ, Orellana-Jimenez C, Melot C, De Backer D, Berre J, Leeman M, Brimioulle S, Appoloni O, Creteur J, Vincent JL: Albumin administration improves organ function in critically ill hypoalbuminemic patients: a prospective, randomized, controlled, pilot study. Crit Care Med 2006, 34:2536-2540
17. Powers KA, Kapus A, Khadaroo RG, He R, Marshall JC, Lindsay TF, Rotstein OD: Twenty-five percent albumin prevents lung injury following shock/resuscitation. Crit Care Med 2003, 31:2355-2363
18. Chalupsky K, Lobysheva I, Nepveu F, Gadea I, Beranova P, Entlicher G, Stoclet JC, Muller B: Relaxant effect of oxime derivatives in isolated rat aorta: role of nitric oxide (NO) formation in smooth muscle. Biochem Pharmacol 2004, 67:1203-1214
19. Vincent JL, Gerlach H: Fluid resuscitation in severe sepsis and septic shock: an evidence-based review. Crit Care Med 2004, 32:S451-S454
20. Vincent JL, Sakr Y, Reinhart K, Sprung CL, Gerlach H, Ranieri VM: Is albumin administration in the acutely ill associated with increased mortality? Results of the SOAP study. Crit Care 2005, 9:R745-R754
21. Walley KR, McDonald TE, Wang Y, Dai S, Russell JA: Albumin resuscitation increases cardiomyocyte contractility and decreases nitric oxide synthase II expression in rat endotoxemia. Crit Care Med 2003, 31:187-194
22. Landry DW, Oliver JA: The pathogenesis of vasodilatory shock. N Engl J Med 2001, 345:588-595
23. Hernanz R, Alonso MJ, Zibrandtsen H, Alvarez Y, Salaices M, Simonsen U: Measurements of nitric oxide concentration and hyporeactivity in rat superior mesenteric artery exposed to endotoxin. Cardiovasc Res 2004, 62:202-211
24. Quinlan GJ, Margarson MP, Mumby S, Evans TW, Gutteridge JM: Administration of albumin to patients with sepsis syndrome: a possible beneficial role in plasma thiol repletion. Clin Sci 1998, 95:459-465
25. Kouoh F, Gressier B, Luyckx M, Brunet C, Dine T, Cazin M, Cazin JC: Antioxidant properties of albumin: effect on oxidative metabolism of human neutrophil granulocytes. Il Farmaco 1999, 54:695-699
26. Jacob M, Bruegger D, Rehm M, Stoeckelhuber M, Welsch U, Conzen P, Becker BF: The endothelial glycocalyx affords compatibility of Starling's principle and high cardiac interstitial albumin levels. Cardiovasc Res 2007, 73:575-586
27. Tiruppathi C, Song W, Bergenfeldt M, Sass P, Malik AB: Gp60 activation mediates albumin transcytosis in endothelial cells by tyrosine kinase-dependent pathway. J Biol Chem 1997, 272:25968-25975
28. Cuzzocrea S, Mazzon E, Di Paola R, Esposito E, Macarthur H, Matuschak GM, Salvemini D: A role for nitric oxide-mediated peroxynitrite formation in a model of endotoxin-induced shock. J Pharmacol Exp Ther 2006, 319:73-81
29. Szabó C, Zingarelli B, Salzman AL: Role of poly-ADP ribosyltransferase activation in the vascular contractile and energetic failure elicited by exogenous and endogenous nitric oxide and peroxynitrite. Circ Res 1996, 78:1051-1063
30. Alderson P, Bunn F, Lefebvre C, Li WP, Li L, Roberts I, Schierhout G: Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev 2004, CD001208 pp 1-28